The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T‐cell activation
- 21 April 2009
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 229 (1), 244-258
- https://doi.org/10.1111/j.1600-065x.2009.00783.x
Abstract
CD160 is a newly identified ligand for HVEM (herpes virus entry mediator). Previously identified HVEM ligands include BTLA (B- and T-lymphocyte attenuator), LIGHT (lymphotoxin-like, exhibits inducible expression, and competes with herpes simplex virus glycoprotein D for HVEM, a receptor expressed by T lymphocytes) and LTalpha (lymphotoxin-alpha). The binding of LIGHT or LTalpha to HVEM delivers a costimulatory signal, whereas the binding of BTLA or CD160 to HVEM delivers a coinhibitory signal. Thus, HVEM is a bidirectional switch regulating T-cell activation in a costimulatory or coinhibitory fashion whose outcome depends on the ligand engaged. The cysteine-rich domain 1 (CRD1) of HVEM is essential for the binding of coinhibitory ligands CD160 and BTLA but not costimulatory ligand LIGHT. Deletion or blockade of HVEM CRD1 abolishes the binding of CD160 and BTLA, but not LIGHT, and converts HVEM to a dominant costimulatory molecule, possibly through the loss of negative signaling by CD160/BTLA. Therapies targeting the CRD1 of HVEM to block BTLA and CD160 binding are being developed to enhance immune responses and vaccination.Keywords
This publication has 147 references indexed in Scilit:
- Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infectionNature Immunology, 2008
- The TNF receptor and Ig superfamily members form an integrated signaling circuit controlling dendritic cell homeostasisCytokine & Growth Factor Reviews, 2008
- Development of autoimmune hepatitis–like disease and production of autoantibodies to nuclear antigens in mice lacking B and T lymphocyte attenuatorArthritis & Rheumatism, 2008
- GPI-anchored receptor clusters transiently recruit Lyn and Gα for temporary cluster immobilization and Lyn activation: single-molecule tracking study 1The Journal of cell biology, 2007
- Identification of a novel functional specificity signal within the GPI anchor signal sequence of carcinoembryonic antigenThe Journal of cell biology, 2007
- Fatty Acid Remodeling of GPI-anchored Proteins Is Required for Their Raft AssociationMolecular Biology of the Cell, 2007
- Reinvigorating exhausted HIV-specific T cells via PD-1–PD-1 ligand blockadeThe Journal of Experimental Medicine, 2006
- Intrinsic Lymphotoxin-β Receptor Requirement for Homeostasis of Lymphoid Tissue Dendritic CellsImmunity, 2005
- BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1Nature Immunology, 2003
- Splenic T Zone Development Is B Cell DependentThe Journal of Experimental Medicine, 2001